Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Integrated transcriptomic and functional analysis identifies NEK2 as a miR‑486‑5p‑regulated mitotic driver in ovarian cancer

View through CrossRef
Abstract Background: Dysregulation of mitotic kinases such as NEK2 is a key driver of centrosome amplification, mitotic spindle defects, and chromosomal instability in cancer. However, the upstream post-transcriptional regulation of NEK2 in ovarian cancer remains poorly characterized. MicroRNA-486-5p (miR-486-5p) has been identified as a tumor-suppressive miRNA and a direct negative regulator of NEK2 in multiple solid tumors. Methods: NEK2 expression was evaluated in two independent ovarian cancer microarray datasets and further validated using RNA-seq data from TCGA-OV and GTEx normal ovarian tissues. Potential upstream miRNAs targeting NEK2 were systematically predicted using miRWalk, TargetScan, and miRDB, then prioritized by integrating miRNA expression profiles from GSE131790 and AGO-CLIP-seq-supported interactions from starBase. Functional validation was performed in SKOV-3 ovarian cancer cells transfected with miR-486-5p mimics or negative control. miR-486-5p and NEK2 mRNA levels were quantified by qRT-PCR, NEK2 protein expression by Western blotting, and apoptosis by Annexin V-FITC/PI flow cytometry. Results: NEK2 was consistently and significantly overexpressed in ovarian tumors compared with normal ovarian tissue across all cohorts examined. Multi-layered integrative analysis identified miR-486-5p as a high-confidence upstream regulator of NEK2, supported by conserved 3′UTR binding sites, consistent downregulation in ovarian cancer, and AGO-CLIP-seq validation. Transfection with miR-486-5p mimics markedly suppressed both NEK2 mRNA and protein levels in SKOV-3 cells. Functionally, restoration of miR-486-5p significantly increased the proportion of apoptotic cells. Conclusion: These findings demonstrate that restoration of miR-486-5p attenuates NEK2 expression, inhibits proliferation, and promotes apoptosis in ovarian cancer cells. The miR-486-5p/NEK2 axis therefore represents a promising molecular target for therapeutic intervention in ovarian cancer.
Springer Science and Business Media LLC
Title: Integrated transcriptomic and functional analysis identifies NEK2 as a miR‑486‑5p‑regulated mitotic driver in ovarian cancer
Description:
Abstract Background: Dysregulation of mitotic kinases such as NEK2 is a key driver of centrosome amplification, mitotic spindle defects, and chromosomal instability in cancer.
However, the upstream post-transcriptional regulation of NEK2 in ovarian cancer remains poorly characterized.
MicroRNA-486-5p (miR-486-5p) has been identified as a tumor-suppressive miRNA and a direct negative regulator of NEK2 in multiple solid tumors.
Methods: NEK2 expression was evaluated in two independent ovarian cancer microarray datasets and further validated using RNA-seq data from TCGA-OV and GTEx normal ovarian tissues.
Potential upstream miRNAs targeting NEK2 were systematically predicted using miRWalk, TargetScan, and miRDB, then prioritized by integrating miRNA expression profiles from GSE131790 and AGO-CLIP-seq-supported interactions from starBase.
Functional validation was performed in SKOV-3 ovarian cancer cells transfected with miR-486-5p mimics or negative control.
miR-486-5p and NEK2 mRNA levels were quantified by qRT-PCR, NEK2 protein expression by Western blotting, and apoptosis by Annexin V-FITC/PI flow cytometry.
Results: NEK2 was consistently and significantly overexpressed in ovarian tumors compared with normal ovarian tissue across all cohorts examined.
Multi-layered integrative analysis identified miR-486-5p as a high-confidence upstream regulator of NEK2, supported by conserved 3′UTR binding sites, consistent downregulation in ovarian cancer, and AGO-CLIP-seq validation.
Transfection with miR-486-5p mimics markedly suppressed both NEK2 mRNA and protein levels in SKOV-3 cells.
Functionally, restoration of miR-486-5p significantly increased the proportion of apoptotic cells.
Conclusion: These findings demonstrate that restoration of miR-486-5p attenuates NEK2 expression, inhibits proliferation, and promotes apoptosis in ovarian cancer cells.
The miR-486-5p/NEK2 axis therefore represents a promising molecular target for therapeutic intervention in ovarian cancer.

Related Results

Nek2 Stabilization By Usp7 Leads to Activation of NF-Kb in Multiple Myeloma
Nek2 Stabilization By Usp7 Leads to Activation of NF-Kb in Multiple Myeloma
Abstract NIMA (Never In Mitosis Gene A)-Related Kinase 2 (Nek2), a centrosomal Serine/Threonine kinase, is a key player in numerous malignancies. Overexpression of N...
Abstract 1571: Nek2 as an effective molecular target for cancer treatment
Abstract 1571: Nek2 as an effective molecular target for cancer treatment
Abstract Nek2 (NIMA-related kinase 2) is a member of the serine/threonine kinase family, Nek, structurally related to the essential mitotic regulator NIMA. Nek2 is i...
Abstract 907: The efficiency of Nek2 siRNA for liver metastasis of pancreatic cancer
Abstract 907: The efficiency of Nek2 siRNA for liver metastasis of pancreatic cancer
Abstract Background: Nek2 (NIMA-related kinase 2) is a member of the serine/threonine kinase family, which related to the essential mitotic regulator NIMA. Nek2 is i...
Abstract 1634: Reduced NIMA-related kinase 2 (Nek2) expression levels enhance paclitaxel sensitivity in breast cancer cells
Abstract 1634: Reduced NIMA-related kinase 2 (Nek2) expression levels enhance paclitaxel sensitivity in breast cancer cells
Abstract While many clinical trials have shown that the taxane, paclitaxel (Taxol™), is a very powerful anticancer drug, paclitaxel is still controversial in its app...
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Abstract Abstract 3896 Poster Board III-832 We previously reported the finding of significantly raised levels of mature microRNA 16 (mi...

Back to Top